Please assess the completion status of the following clinical trial:

Trial Title: Immediate Implant Breast Reconstruction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed breast carcinoma~* Patients planned for mastectomy with immediate single stage breast reconstruction using an acellular dermal matrix (Strattice™, LifeCell Corporation)~* Patients planned to receive postoperative chest wall irradiation~* Age ≥ 18 years old~* WHO performance status 0-1~* Affiliation to a social security system~* Informed consent signed prior any study specific procedures~Exclusion Criteria:~* Inflammatory breast cancer~* Tumors with extensive involvement of the skin~* Use of tissue expander~* Indication of postoperative chemotherapy~* Patients planned for bilateral mastectomy~* History of previously treated ipsilateral breast carcinoma~* Usual contraindications for ADM~* Medical debility precluding surgical treatment~* Psychological, social, geographical disorders or any other condition that would preclude study compliance (treatment modalities and study follow-up).~* Pregnancy or breast feeding~* Inability to attend or comply with interventions or follow-up scheduling, disability or difficulty preventing a proper understanding of trial instructions~* Legal inability or restricted legal ability

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- immediate implant breast reconstruction (Type: EXPERIMENTAL): immediate implant breast reconstruction

Based on this trial design, predict the completion outcome and termination type (if applicable).